Atossa Therapeutics (ATOS) Shares Outstanding (2011 - 2026)

Atossa Therapeutics (ATOS) has reported Shares Outstanding (Entity) for 16 consecutive years, with $8.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) changed 0.0% year-over-year to $8.6 million; the TTM figure through Mar 2026 stood at $8.6 million (changed 0.0% YoY), while the FY2025 annual figure was $8.6 million, changed 0.0% from the prior year.
• Shares Outstanding (Entity) was little changed at $8.6 million in Q1 2026 per ATOS's latest filing, from $8.6 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $8.6 million in Q2 2025 and bottomed at $8.4 million in Q3 2023.
• Historically, Shares Outstanding (Entity) has averaged $8.5 million across 5 years, with a median of $8.4 million in 2022.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) jumped 108172.69% — and 2023, when it decreased 1.04%.
• Atossa Therapeutics' Shares Outstanding (Entity) stood at $8.4 million in 2022, then decreased by 1.04% to $8.4 million in 2023, then rose by 3.09% to $8.6 million in 2024, then slipped by 0.0% to $8.6 million in 2025, then changed by 0.0% to $8.6 million in 2026.
• Business Quant data shows ATOS's Shares Outstanding (Entity) at $8.6 million in Q1 2026, $8.6 million in Q4 2025, and $8.6 million in Q3 2025.